IntermediatecardiovascularPhysiology

Hemostasis: How Bleeding Stops

Overview

Hemostasis stops bleeding through five coordinated stages: immediate vascular spasm narrows the injured vessel, platelets adhere and aggregate into a plug, the coagulation cascade generates thrombin and a fibrin mesh, the clot retracts to draw wound edges together, and fibrinolysis later dissolves the clot as healing proceeds. The intrinsic and extrinsic pathways converge on factor X and the common pathway; PT/INR monitors the extrinsic pathway and aPTT the intrinsic. Vitamin K is required to synthesize factors II, VII, IX, and X.

Learning objectives

  • List the five stages of hemostasis in order.
  • Explain platelet adhesion and aggregation, including the roles of vWF and fibrinogen.
  • Trace the intrinsic, extrinsic, and common coagulation pathways to fibrin formation.
  • Interpret what PT/INR and aPTT each measure.
  • Describe fibrinolysis and the role of plasmin.

Process steps

1
Injury exposes subendothelial collagen

When a vessel wall is breached, blood contacts collagen and tissue factor normally hidden beneath the endothelium. This exposure is the trigger for everything that follows: it initiates platelet adhesion and activates the coagulation cascade, while the loss of endothelial prostacyclin and nitric oxide removes the local brakes on clotting.

2
Vascular spasm narrows the vessel

Within seconds, smooth muscle in the injured vessel contracts - triggered by direct injury, pain reflexes, and chemicals released by platelets (serotonin, thromboxane A2) and damaged endothelium (endothelin-1). Spasm reduces blood flow through the breach, buying time for the plug and clot to form; it is most effective in small vessels.

3
Platelets adhere via von Willebrand factor

Platelets bind exposed collagen through von Willebrand factor (vWF), which acts as a bridge between collagen and platelet GPIb receptors - essential under the high shear of arterial flow. Adherent platelets activate: they change shape, extend pseudopods, and empty granules containing ADP, serotonin, and more vWF.

4
Aggregation builds the platelet plug

Released ADP and newly synthesized thromboxane A2 recruit and activate nearby platelets, which express GPIIb/IIIa receptors that bind fibrinogen, linking platelets together into a growing aggregate. This primary hemostatic plug is fast but fragile - it must be reinforced by fibrin to become durable.

5
The extrinsic pathway activates rapidly

Damaged tissue releases tissue factor (factor III), which complexes with factor VIIa to activate factors X and IX directly. Because tissue factor is abundant at injury sites, the extrinsic pathway is the fast in-vivo initiator of coagulation, measured in the laboratory by the prothrombin time (PT/INR).

6
The intrinsic pathway amplifies the response

Exposed collagen activates factor XII, which triggers a cascade through XI, IX (with VIII as cofactor), amplifying the signal enormously. Though slower to start, the intrinsic pathway generates the bulk of thrombin; it is monitored by the activated partial thromboplastin time (aPTT).

7
The common pathway produces thrombin and fibrin

Both pathways converge on factor X, which with factor V converts prothrombin (II) to thrombin (IIa). Thrombin - the central enzyme of coagulation - converts soluble fibrinogen into fibrin monomers that polymerize into a mesh, and activates factor XIII, which cross-links the mesh into a tough, insoluble clot trapping cells and the platelet plug.

8
Clot retraction consolidates the seal

Platelet contractile proteins (actin and myosin) pull on the fibrin strands, squeezing serum out and shrinking the clot. Retraction draws wound edges together and produces a firmer, more compact seal that resists dislodgement by blood pressure.

9
Fibrinolysis dissolves the clot during healing

As tissue repairs, tissue plasminogen activator (tPA) from endothelium converts plasminogen to plasmin, which digests fibrin into degradation products (including D-dimer). This controlled demolition removes the clot once the vessel wall is restored, reopening the lumen.

10
Anticoagulant systems confine clotting

Clotting is kept local by circulating inhibitors: antithrombin inactivates thrombin and factor Xa, protein C (with protein S) destroys factors Va and VIIIa, and tissue factor pathway inhibitor blocks the extrinsic complex. Together with intact endothelium's prostacyclin and nitric oxide, they ensure the clot forms at the injury and nowhere else.

Key variables

VariableUnitTypical rangeRole
Prothrombin time / INRseconds / ratioPT 11-13 s; INR ~1.0Measures the extrinsic and common pathways (factors VII, X, V, II, fibrinogen); prolonged by warfarin.
Activated partial thromboplastin timeseconds25-35Measures the intrinsic and common pathways (XII, XI, IX, VIII, X, V, II); prolonged by heparin.
Platelet countplatelets/µL150,000-400,000Adequate numbers are required for primary hemostasis; low counts prolong bleeding time.
Fibrinogenmg/dL200-400Substrate for the fibrin mesh; the first factor depleted in massive bleeding.
Vitamin K-dependent factorsfactorsII, VII, IX, X (plus proteins C and S)Require vitamin K for gamma-carboxylation; their deficiency underlies warfarin's anticoagulant effect.

Feedback loops

Thrombin positive feedback positive feedback

  1. Initial thrombin is generated by the extrinsic pathway
  2. Thrombin activates factors V, VIII, and XI
  3. Activated cofactors massively accelerate further thrombin generation
  4. Explosive thrombin burst produces the fibrin mesh rapidly

Protein C anticoagulant brake negative feedback

  1. Thrombin binds thrombomodulin on intact endothelium
  2. The complex activates protein C
  3. Activated protein C (with protein S) destroys factors Va and VIIIa
  4. Thrombin generation shuts down beyond the injury site

Fibrinolytic balance negative feedback

  1. Fibrin forms within the clot
  2. tPA converts plasminogen to plasmin on the fibrin surface
  3. Plasmin digests fibrin as healing proceeds
  4. Plasminogen activator inhibitor-1 limits plasmin to prevent premature lysis

Hemostasis in five stages

Hemostasis - literally 'blood standing still' - is the body's rapid response to vascular injury, unfolding in five overlapping stages. Vascular spasm immediately reduces flow through the breach. Platelet plug formation (primary hemostasis) seals small gaps within minutes. Coagulation (secondary hemostasis) reinforces the plug with fibrin over several more minutes. Clot retraction compacts the seal, and fibrinolysis eventually dismantles it. Each stage compensates for the others: platelets alone cannot stop large-vessel bleeding, and fibrin without platelets forms slowly.

Primary vs secondary hemostasis

Primary hemostasis = the platelet plug (fast, fragile). Secondary hemostasis = the fibrin clot via the coagulation cascade (slower, durable). Disorders of platelets cause mucosal bleeding; factor deficiencies cause deep tissue bleeding.

The platelet plug: adhesion and aggregation

Platelet adhesion depends on von Willebrand factor bridging exposed collagen to platelet GPIb receptors - critical where fast arterial flow would otherwise wash platelets away. Once adherent, platelets activate and release ADP and thromboxane A2, potent recruiters that switch nearby platelets' GPIIb/IIIa receptors into fibrinogen-binding mode, cross-linking the growing aggregate. This positive-feedback recruitment is why a tiny initial adhesion can build a plug large enough to seal the breach - and why intact endothelium nearby must actively oppose it with prostacyclin and nitric oxide to keep the plug localized.

The coagulation cascade: two roads to factor X

The classic cascade has three parts. The extrinsic pathway (tissue factor + VIIa -> X) is the rapid in-vivo trigger at injury sites. The intrinsic pathway (XII -> XI -> IX -> VIII -> X on a phospholipid surface) amplifies the signal through a cascade of zymogen activations. Both converge on the common pathway: factor Xa with Va converts prothrombin to thrombin, and thrombin converts fibrinogen to fibrin while activating factor XIII to cross-link it. Calcium ions (factor IV) are required at multiple steps, and the reactions assemble on negatively charged phospholipid surfaces provided by activated platelets.

Why two pathways?

In the test tube they are separate assays (PT vs aPTT), but in the body they work as one integrated system: the extrinsic pathway initiates, the intrinsic pathway amplifies, and thrombin feedback accelerates both.

Thrombin: the central enzyme

Thrombin sits at the hub of coagulation with four jobs: it converts fibrinogen to fibrin, activates factor XIII to cross-link the mesh, activates platelets through PAR receptors, and - paradoxically - initiates its own shutdown by activating protein C on intact endothelium. It also amplifies its own production by activating factors V, VIII, and XI, creating the explosive positive-feedback burst that converts a slow trickle of initial activation into a full clot within minutes.

Reading the clotting tests

PT/INR and aPTT each interrogate part of the cascade. The prothrombin time adds tissue factor to plasma, testing the extrinsic and common pathways (VII, X, V, II, fibrinogen); the INR standardizes PT for monitoring vitamin K antagonists like warfarin, which deplete factors II, VII, IX, and X. The aPTT adds a contact activator and phospholipid, testing the intrinsic and common pathways (XII, XI, IX, VIII, X, V, II); it monitors heparin, which accelerates antithrombin. A prolonged test points to the deficient pathway - the map every clinician uses.

Educational interpretation only

This explains what the tests measure physiologically. Ordering or interpreting clotting tests for a real person is clinical work, not covered here.

Fibrinolysis: controlled demolition

A clot is temporary scaffolding. Endothelial cells release tissue plasminogen activator (tPA), which binds fibrin and converts trapped plasminogen into plasmin - a protease that digests the fibrin mesh into fragments including D-dimer. Plasminogen activator inhibitor-1 (PAI-1) restrains the system so lysis follows healing rather than preceding it. The balance between coagulation and fibrinolysis determines whether a vessel stays sealed, reopens cleanly, or bleeds again.

Key points

  • Hemostasis has five stages: vascular spasm, platelet plug, coagulation, clot retraction, fibrinolysis.
  • vWF bridges platelets to exposed collagen; fibrinogen cross-links platelets via GPIIb/IIIa.
  • Extrinsic pathway (tissue factor/VIIa) initiates; intrinsic pathway (XII→XI→IX→VIII) amplifies.
  • Both pathways converge on factor X → thrombin → fibrin, cross-linked by factor XIII.
  • Thrombin provides positive feedback by activating factors V, VIII, and XI.
  • PT/INR tests the extrinsic pathway; aPTT tests the intrinsic pathway.
  • Vitamin K is required for factors II, VII, IX, and X (and proteins C and S).
  • Plasmin dissolves fibrin during healing; D-dimer is a fibrin breakdown product.

Common misconceptions

✗ Myth: The intrinsic and extrinsic pathways operate independently in the body.

✓ Truth: They are laboratory distinctions. In vivo they form one integrated system: tissue factor/VIIa initiates coagulation, the intrinsic factors amplify it, and thrombin feedback ties them together.

✗ Myth: A blood clot is permanent once formed.

✓ Truth: Clots are temporary. Fibrinolysis - plasmin digesting fibrin - dismantles the clot as the vessel wall heals, restoring the lumen. Persistent clots reflect failed or overwhelmed fibrinolysis.

✗ Myth: Platelets alone are enough to stop bleeding from any injury.

✓ Truth: The platelet plug is fast but fragile and suffices only for small breaches. Larger injuries require the fibrin mesh of secondary hemostasis to reinforce it - which is why factor deficiencies cause deep, prolonged bleeding.

Practice questions

Q1. Which laboratory test monitors the extrinsic coagulation pathway and is used to follow warfarin therapy?
  1. aPTT
  2. Bleeding time
  3. PT/INR
  4. D-dimer
Answer: C.

PT adds tissue factor, testing the extrinsic and common pathways (VII, X, V, II, fibrinogen). Warfarin depletes vitamin K-dependent factors including VII, so PT/INR - standardized as the International Normalized Ratio - tracks its effect.

Q2. A patient lacks von Willebrand factor. Which hemostatic step is most directly impaired?
  1. Vascular spasm
  2. Platelet adhesion to exposed collagen under flow
  3. Thrombin generation in the common pathway
  4. Fibrinolysis by plasmin
Answer: B.

vWF bridges platelet GPIb receptors to exposed subendothelial collagen, especially under high shear. Without it, platelets cannot adhere efficiently, so primary hemostasis (the platelet plug) is defective while the coagulation cascade itself remains intact.

Q3. Thrombin amplifies its own production by activating which factors?
  1. Factors XII and XI only
  2. Factors V, VIII, and XI
  3. Factors VII and X
  4. Protein C and protein S
Answer: B.

Thrombin activates the cofactors V and VIII and factor XI, massively accelerating the tenase and prothrombinase complexes. This positive feedback converts slow initial activation into the explosive thrombin burst that forms fibrin rapidly.

Q4. Factor XIII's role in the clot is to:
  1. Convert fibrinogen to fibrin
  2. Cross-link fibrin monomers into a stable, insoluble mesh
  3. Activate platelets via ADP release
  4. Dissolve the clot during healing
Answer: B.

Thrombin converts fibrinogen to fibrin monomers that polymerize; factor XIIIa (activated by thrombin) then forms covalent cross-links between fibrin strands, creating the tough, insoluble mesh that stabilizes the clot. Plasmin later dissolves it.

Click a question to reveal the answer and explanation.

Frequently asked questions

What is the difference between PT/INR and aPTT?

PT (reported as INR) adds tissue factor to test the extrinsic and common pathways - factors VII, X, V, II, and fibrinogen - and monitors warfarin. aPTT uses a contact activator to test the intrinsic and common pathways - XII, XI, IX, VIII, X, V, II - and monitors heparin. Together they localize a defect to one pathway.

Why does warfarin affect PT/INR rather than aPTT?

Warfarin blocks vitamin K-dependent gamma-carboxylation of factors II, VII, IX, and X. Factor VII has the shortest half-life (~6 hours), so the extrinsic pathway - measured by PT/INR - prolongs first and most sensitively.

What role does calcium play in coagulation?

Calcium (factor IV) bridges the gamma-carboxylated clotting factors to negatively charged phospholipid surfaces on activated platelets, assembling the tenase and prothrombinase complexes. Without calcium, the cascade cannot localize or proceed - which is why citrate (a calcium chelator) anticoagulates donated blood.

How does the body prevent clots from spreading throughout the circulation?

Three safeguards: clotting factors activate mainly on phospholipid surfaces at the injury; circulating inhibitors (antithrombin, protein C/S, TFPI) neutralize stray activated factors; and intact endothelium releases prostacyclin and nitric oxide to keep nearby platelets quiet. Clotting stays local because activation is local and inhibition is systemic.

What is D-dimer and why is it measured?

D-dimer is a fragment released when plasmin digests cross-linked fibrin - so it indicates that both clotting and fibrinolysis have occurred. It is a sensitive but nonspecific marker: elevated in thrombosis but also in inflammation, pregnancy, and many other states.